Minimal Residual Disease (MRD) Assessment in the Management of Lymphoid Malignancies

This Minimal Residual Disease (MRD) webinar will address recent data supporting real world utility of MRD assessment as a prognostic marker, provide evidence to support the increased role of MRD as a response assessment tool and the impact of MRD in novel therapies in clinical practice. A review of MRD testing methodologies will also be covered.